Phase 4
Completed N=41
LigaSure Small Jaw® Versus Conventional Neck Dissection in Head and Neck Cancer Patients
Source: ClinicalTrials.gov NCT02597582 ↗Enrolled (actual)
41
Serious AEs
0.0%
Results posted
Oct 2016
Primary outcomePrimary: Opreation Duration — 97.1; 116.3 minutes — p=0.022
◆ Published Evidence
Emerging
7citations · ~1 / year
A prospective randomised trial of LigaSure Small Jaw® versus conventional neck dissection in head and neck cancer patients.
Summary
The aim of this prospective randomized study was to investigate if the LigaSure vessel sealing system can reduce the operation duration and the postoperative drainage amount in patients undergoing neck dissection.
Linked Publications
-
A prospective randomised trial of LigaSure Small Jaw® versus conventional neck dissection in head and neck cancer patients.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Opreation Duration |
97.1; 116.3 | 0.022 sig |
| SECONDARY Intraoperative Blood Loss |
122; 144 | 0.266 |
| SECONDARY Postoperative Drainage Amount |
107; 139 | 0.060 |
| SECONDARY Postoperative Subjective Pain Status |
0.6; 0.7; 3.5; 3.4; 2.5; 2.6 | — |
| SECONDARY Postoperative Oral Analgesic Consumption |
37.2; 40.9 | 0.524 |
| SECONDARY Postoperative Injected Analgesic Amount |
8.8; 17.7 | 0.037 sig |
Eligibility Criteria
Inclusion Criteria
- Patients aged 20 to 80 years scheduled to receive neck dissection due to head and neck cancer
Exclusion Criteria
- history of coagulation disorders
- prior radiation to the neck
- prior neck dissection
- declined to participate
Data sourced from ClinicalTrials.gov (NCT02597582) and the linked publication. Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.